Categories: News

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 financial results on Thursday, May 8th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call, as well as a webcast, can be accessed from the “Investors” section of Enovis’ website at www.enovis.com.

Conference Call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 335-0887 and use the Access Code: 482081. Participants may also preregister at this link. A replay of the call will also be available on the Enovis website later that day.

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Availability of Information on the Enovis Website

Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

Staff

Recent Posts

Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®

New collaboration delivers 50% off prescription sleep support for new customers who are struggling with…

5 hours ago

EnrollHere and SunFire Announce Strategic Partnership to Deliver Seamless, End-to-End Medicare Enrollment Technology

WILMINGTON, N.C. , June 9, 2025 /PRNewswire/ -- EnrollHere, a next-generation Medicare technology platform, and SunFire,…

5 hours ago

Chicago Faucets Hosts Public Health Webinar to Help Facilities Comply with Emerging Legionella Regulations

Spenser Johnson to Present "Navigating Evolving Water Management Regulations: Ensuring Compliance & Public Safety" Thursday,…

5 hours ago

Dr. Sameer Berry, Oshi Health Co-Founder and Chief Medical Officer, Named to Modern Healthcare’s 50 Most Influential Clinical Executives

In helping create and scale Oshi as the first nationwide virtual GI clinic, Berry has…

5 hours ago

Washington County, NY Sheriff’s Office First in the Nation to Provide Sheriff Rx™

Prescription Discount Program for County Employees in Partnership with BI2 Technologies, LLC FORT EDWARD, N.Y.,…

5 hours ago

Sage Adds AI-Powered Fall Detection and Wellness Trend Monitoring to its All-in-One Senior Care Platform

NEW YORK, June 9, 2025 /PRNewswire/ -- Sage, the first cloud-based operating system built for senior…

5 hours ago